HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NPD Group on color

This article was originally published in The Rose Sheet

Executive Summary

Prestige bronzers posted 17% growth in the first quarter versus a year ago, indicating their growing importance as women want color without spending hours in the sun, NPD Group reports May 25. The performance of bronzers compares with a 5% decline in traditional prestige blushes during the quarter, firm notes. Bronzers have quadrupled in dollar share since 1997, NPD adds, noting in the first quarter of 1997 they made up 6% of dollar sales of the prestige blush category, while in Q1 2006 they accounted for 24% of sales in the segment. Separately, group reports growth of prestige eye color, which was up 10% to $840 mil. in 2005. Additionally, 66% more brands are selling eyeshadows now than six years ago, and eyeshadow became the only makeup category other than foundation to break the $300 mil. mark, according to NPD Group...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013966

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel